Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 20, 2020, the board of directors (the "Board") of Akers Biosciences, Inc. (the "Company") appointed Joshua Silverman, a current director of the Company, as Chairman of the Board. On November 20, 2020, Christopher C. Schreiber, the current principal executive officer and President of the Company, resigned from his position as Executive Chairman of the Board, and the Board appointed him as Chief Executive Officer of the Company, effective November 20, 2020, with Mr. Schreiber to continue serving as the Company's principal executive officer and president. Mr. Schreiber's current employment agreement with the Company will remain in effect.

© Edgar Online, source Glimpses